CYP450 2C9 drug metabolizing enzyme and VKORC1 genotyping system
ODV,ODW
Vitamin k epoxide reductase complex subunit one (vkorc1) genotyping system,Cytoc
Vitamin k epoxide reductase complex subunit one (vkorc1) genotyping system,Cytochrome P450 2C9 (Cyp450 2c9) drug metabolizing enzyme genotyping system
CYP2C19 drug metabolyzing enzyme genotyping system
NSU,NTI
Instrumentation for clinical multiplex test systems,Drug metabolizing enzyme gen
Instrumentation for clinical multiplex test systems,Drug metabolizing enzyme genotyping systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
NPQ,NSU,NPR
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems,TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR
CYP2C19 drug metabolyzing enzyme genotyping system
NTI,NSU
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multipl
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutation
NPR,NSU
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
NPQ,NPR,NSU
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,TEST, FACTOR II G20210A MUTATIO
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
NSU,NPQ,NPR
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATI
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR
Genotyping system for the detection of Factor II (Prothrombin) G20210A mutations.
NPR,NSU
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical
TEST, FACTOR II G20210A MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
Genotyping systme for the detection of the Factor V Leiden G1691A mutation
NSU,NPQ
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATI
Instrumentation for clinical multiplex test systems,TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR
Genotyping system for the detection of the Factor V Leiden G1691A mutation
NPQ,NSU
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
2
INFINITI® Factor V Leiden BioFilmChip® Microarray Magazine
CYP2C19 drug metabolyzing enzyme genotyping system
NTI,NSU
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multipl
Drug metabolizing enzyme genotyping systems,Instrumentation for clinical multiplex test systems
Genotyping system for the detection of the Factor V Leiden G1691A mutation
NPQ,NSU
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical mu
TEST, FACTOR V LEIDEN MUTATIONS, GENOMIC DNA PCR,Instrumentation for clinical multiplex test systems
2
INFINITI® Factor V Leiden Intellipac® Reagent Module
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of res
In-vitro multiplex assay used with the Biocode MDx 3000 for the detection of respiratory pathogens.
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Facto
Genotyping system for the detection of Factor II (Prothrombin) G20210A and Factor V Leiden G1691A mutations
The MAGPIX Drive Fluid PLUS serves as the delivery medium that carries the sampl
The MAGPIX Drive Fluid PLUS serves as the delivery medium that carries the sample to the optics component of the MAGPIX instrument.
A concentrated version of xMAP® Sheath Fluid PLUS, when diluted is is the delive
A concentrated version of xMAP® Sheath Fluid PLUS, when diluted is is the delivery medium of the sample to the optics component.
The VERIGENE® II Module is a component of the VERGIENE® II System. When install
The VERIGENE® II Module is a component of the VERGIENE® II System. When installed in the VERIGENE® II System it is capable of automated extraction and purification of nucleic acids from multiple sample types as well as automated amplification, array hybridization, and detection of target nucleic acid sequences.
The VERIGENE® II System is an in vitro diagnostic (IVD) platform that performs n
The VERIGENE® II System is an in vitro diagnostic (IVD) platform that performs nucleic acid based tests in clinical laboratories. The VERIGENE II System is capable of automated extraction and purification of nucleic acids from multiple sample types as well as automated amplification, array hybridization, and detection of target nucleic acid sequences.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F
The Verigene® Hypercoagulation Panel Nucleic Acid Test contains the Verigene® F5 Nucleic Acid Test, the Verigene® F2 Nucleic Acid Test and the Verigene® MTHFR Nucleic Acid Test. The Verigene® F5 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 1691; also known as Factor V Leiden) of the human Factor V gene (F5; Coagulation Factor V gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® F2 Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (G to A at position 20210) of the human Factor II gene (F2; prothrombin gene) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples. The Verigene® MTHFR Nucleic Acid Test is an in vitro diagnostic for the detection and genotyping of a single point mutation (C to T at position 677) of the human 5,10 methylenetetrahydrofolate reductase gene (MTHFR) in patients with suspected thrombophilia, from isolated genomic DNA obtained from whole blood samples.
Hypercoagulation Panel (HC) Nucleic Acid Test Cartridge
The Verigene® Processor is an instrument which internalizes all of the functions
The Verigene® Processor is an instrument which internalizes all of the functions required to process a Test Cartridge as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
The Verigene® Processor SP is an instrument which integrates sample preparation,
The Verigene® Processor SP is an instrument which integrates sample preparation, target amplification, and target hybridization within a single device as part of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications.
The Verigene® Reader is the central control of the Verigene® System, a benchtop
The Verigene® Reader is the central control of the Verigene® System, a benchtop molecular diagnostics workstation that utilizes patented gold nanoparticle technology to detect nucleic acid targets of interest for a variety of applications. (Refurbished)
The MAGPIX Drive Fluid serves as the delivery medium that carries the sample to
The MAGPIX Drive Fluid serves as the delivery medium that carries the sample to the optics component of the MAGPIX instrument.
The xTAG® Gastrointestinal Pathogen Panel (GPP) is a qualitative multiplex test
The xTAG® Gastrointestinal Pathogen Panel (GPP) is a qualitative multiplex test intended for the simultaneous detection and identification of nucleic acids from multiple gastroenteritis causing viruses, parasites and bacteria (including toxin gene detection) in human stool samples that are fresh, frozen or in a holding medium, from individuals with signs and symptoms of infectious colitis or gastroenteritis.
The xTAG® Respiratory Viral Panel (RVP) is a qualitative nucleic acid multiplex
The xTAG® Respiratory Viral Panel (RVP) is a qualitative nucleic acid multiplex test intended for the simultaneous detection and identification of multiple respiratory virus nucleic acids in nasopharyngeal swabs from individuals suspected of respiratory tract infections.
The Luminex® FLEXMAP 3D® Calibration Kit contains all reagents needed for 25 cal
The Luminex® FLEXMAP 3D® Calibration Kit contains all reagents needed for 25 calibrations of the FLEXMAP 3D® platform with Luminex® xPONENT® software.
The Luminex® FLEXMAP 3D® Performance Verification Kit is used to run performance
The Luminex® FLEXMAP 3D® Performance Verification Kit is used to run performance verification on the FLEXMAP 3D analyzer. The Luminex FLEXMAP 3D® Performance Verification Kit includes sufficient reagents to perform 25 verifications of the calibration and optical integrity for the Luminex FLEXMAP 3D® System.
xMAP Calibrator Microspheres, Classification (CAL1) and Reporter (CAL2), are pol
xMAP Calibrator Microspheres, Classification (CAL1) and Reporter (CAL2), are polystyrene microspheres that are internally labeled with fluorescent dyes. They serve as system calibrators for Luminex xMAP technology based detectors and are intended to normalize the settings for both the classification channel (CL1, CL2), the doublet discriminator channel (DD), and the reporter channel (RP1).
xMAP Control Microspheres, Classification (CON1) and Reporter (CON2), are polyst
xMAP Control Microspheres, Classification (CON1) and Reporter (CON2), are polystyrene microspheres that are internally labeled with fluorescent dyes. The control microspheres are intended to verify the calibration and optical integrity for the Luminex 100/200 System. Classification Control Microspheres verify both classification channels and the doublet discriminator channel (DD). Reporter Control Microspheres verify the reporter channel.